Sheffield Bio-Science to supply Wockhardt recombinant insulin to cell culture market
Reportedly, Wockhardt was the first in Asia and only the fourth company in the world to have developed, manufactured and marketed Wosulin, recombinant insulin injectables. As a result
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.